DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer
作者： A Drouillard , F Puleo , J B Bachet , S Ouazzani , A Calomme
DOI: 10.1038/BJC.2016.319
关键词: Internal medicine 、 Oncology 、 Skin cancer 、 Breast cancer 、 Pancreatic cancer 、 Gemcitabine 、 Lung cancer 、 Medicine 、 Prostate cancer 、 Liver cancer 、 Colorectal cancer
摘要: DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer
nature.com
ulb.ac.be
sci-hub.se 参考文章(27)
Liangjing Zhou, Leilai Yu, Guoping Ding, Wenchao Chen, Sixin Zheng, Liping Cao, Overexpressions of DLL4 and CD105 are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. Pathology & Oncology Research. ,vol. 21, pp. 1141- 1147 ,(2015) , 10.1007/S12253-015-9937-4
Dejuan Kong, Sanjeev Banerjee, Aamir Ahmad, Asfar Sohail Azmi, Shadan Ali, James L. Abbruzzese, Gary E. Gallick, Fazlul H. Sarkar, Zhiwei Wang, Yiwei Li, Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway Cancer Research. ,vol. 69, pp. 2400- 2407 ,(2009) , 10.1158/0008-5472.CAN-08-4312
Irene Noguera-Troise, Christopher Daly, Nicholas J. Papadopoulos, Sandra Coetzee, Pat Boland, Nicholas W. Gale, Hsin Chieh Lin, George D. Yancopoulos, Gavin Thurston, Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis Nature. ,vol. 444, pp. 1032- 1037 ,(2006) , 10.1038/NATURE05355
Hidekazu Oishi, Makoto Sunamura, Shinichi Egawa, Fuyuhiko Motoi, Michiaki Unno, Toru Furukawa, Nagy A. Habib, Hideo Yagita, Blockade of Delta-Like Ligand 4 Signaling Inhibits Both Growth and Angiogenesis of Pancreatic Cancer Pancreas. ,vol. 39, pp. 897- 903 ,(2010) , 10.1097/MPA.0B013E3181CE7185
Hai-Tao Chen, Quan-Cai Cai, Jian-Ming Zheng, Xiao-Hua Man, Hui Jiang, Bin Song, Gang Jin, Wei Zhu, Zhao-Shen Li, High Expression of Delta-Like Ligand 4 Predicts Poor Prognosis After Curative Resection for Pancreatic Cancer Annals of Surgical Oncology. ,vol. 19, pp. 464- 474 ,(2012) , 10.1245/S10434-011-1968-9
Jacob Hald, J.Peter Hjorth, Michael S German, Ole D Madsen, Palle Serup, Jan Jensen, Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development Developmental Biology. ,vol. 260, pp. 426- 437 ,(2003) , 10.1016/S0012-1606(03)00326-9
Wan-Ching Yen, Marcus M Fischer, Mark Hynes, Jingjiang Wu, Edward Kim, Lucia Beviglia, V Pete Yeung, Xiaomei Song, Ann M Kapoun, John Lewicki, Austin Gurney, Diane M Simeone, Timothy Hoey, None, Anti-DLL4 Has Broad Spectrum Activity in Pancreatic Cancer Dependent on Targeting DLL4-Notch Signaling in Both Tumor and Vasculature Cells Clinical Cancer Research. ,vol. 18, pp. 5374- 5386 ,(2012) , 10.1158/1078-0432.CCR-12-0736
Christopher D. Mann, Christopher Bastianpillai, Christopher P. Neal, Muhammad M. Masood, Donald J. L. Jones, Friederike Teichert, Rajinder Singh, Elena Karpova, David P. Berry, Margaret M. Manson, Notch3 and Hey-1 as Prognostic Biomarkers in Pancreatic Adenocarcinoma PLoS ONE. ,vol. 7, pp. e51119- ,(2012) , 10.1371/JOURNAL.PONE.0051119
C. Sahlgren, M. V. Gustafsson, S. Jin, L. Poellinger, U. Lendahl, Notch signaling mediates hypoxia-induced tumor cell migration and invasion Proceedings of the National Academy of Sciences of the United States of America. ,vol. 105, pp. 6392- 6397 ,(2008) , 10.1073/PNAS.0802047105
John Ridgway, Gu Zhang, Yan Wu, Scott Stawicki, Wei-Ching Liang, Yvan Chanthery, Joe Kowalski, Ryan J. Watts, Christopher Callahan, Ian Kasman, Mallika Singh, May Chien, Christine Tan, Jo-Anne S. Hongo, Fred de Sauvage, Greg Plowman, Minhong Yan, Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis Nature. ,vol. 444, pp. 1083- 1087 ,(2006) , 10.1038/NATURE05313